Aztech Global’s Malaysia Facility Obtains FDA Registration for U.S. Medical Device Production

SGX Filings
01/22

Aztech Global Ltd. (8AZ) said on Jan, 22 2026 that its wholly owned manufacturing plant in Pasir Gudang, Johor, IOT Manufacturing Sdn. Bhd., has been registered with the U.S. Food and Drug Administration under 21 CFR Part 807.

The 300,000-square-foot facility, which sits on about 9.11 acres of land, is also ISO 13485 certified, enabling it to produce medical devices under an FDA-aligned quality management system.

With the registration in place, Aztech Global can manufacture, import and market medical devices for customers seeking faster access to the United States, the world’s largest medical device market, valued at roughly 242.3 billion Singapore dollars in 2024.

Malaysia remains a key supply base for the sector, with nearly 37% of its 2024 medical device exports destined for the United States, according to publicly available trade data.

Aztech Global said the new certification complements its existing IoT manufacturing capabilities and supports its strategy to grow as a compliant, scalable partner for medical device owners targeting the U.S. market.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10